Here are the latest notable updates on Spire Healthcare, based on recent public disclosures:
Annual results for 2024 show NHS demand increasing and a focus on high-acuity orthopaedic work, with NHS revenue growth in Q4 and ongoing expansion of eRS slots. Spire also reported progress from the Vita and new Primary Care initiatives, with plans to grow clinics and occupational health services. Expect ongoing cost pressures from NI and minimum wage changes in the near term. [Source: Full-year results press materials and regulatory announcements for 2024-2025 period].
In early 2025, the company reiterated confidence in medium-term targets, highlighting revenue growth in Hospitals of more than 5% and the role of Vita and new clinics in driving downstream revenue, along with strategic NHS partnerships to reduce waiting lists. [Source: Spire Healthcare final results press releases and related investor communications].
There has been continued media attention around strategic options, including potential sale discussions noted by major outlets in 2025–2026, with interest from private equity and market speculation about a take-private scenario. [Source: Reuters/ Sky News reporting on strategic options].
Spire’s ongoing capital expenditure and clinic expansion are part of its broader strategy to diversify services, including occupational health and primary care, to complement hospital activity and address waiting times. [Source: Spire strategic/annual reports].
If you’d like, I can pull the exact passages from the latest documents and provide a concise timeline with key figures (revenue by segment, NHS share, and capex) and add a short chart. I can also set up a quick CSV of the latest figures if you want to review offline.
Spire Healthcare shares jumped almost 16% on Friday after the British private hospital group said it was exploring strategic options, including a potential sale of the company.
www.reuters.comRead all the latest Spire Healthcare Group plc (SPI) Ordinary 1p share news, regulatory announcements and tips.
www.hl.co.uk· Vita outperforming management expectations with revenue of £107m and EBITDA £11m. · Three new Primary Care clinics opened. Meeting more patient needs and driving referrals to nearby Hospitals. · Responded to NHS demand. Increasing eRS slots and driving 20% y/y volume growth in Q4, with high Orthopaedic mix of over 60%. … I thank all our colleagues and consultant partners for their expertise and commitment. We are excited about the future. We remain confident in the combination of structural...
www.stockopedia.comBridgepoint and Triton Partners are among the private equity groups interested in a take-private deal for Britain's biggest private hospitals operator, Sky News learns.
news.sky.comSpire Healthcare Regulatory News. Live SPI RNS. Regulatory News Articles for Spire Healthcare Group Plc Ord 1p
www.lse.co.ukCentres and implementing staffing models to reduce agency use. • Vita outperforming management expectations with revenue of £107m and EBITDA £11m. • Three new Primary Care clinics opened. Meeting more patient needs and driving referrals to nearby Hospitals. • Responded to NHS demand. Increasing eRS slots and driving 20% y/y volume growth in Q4, with high Orthopaedic mix of over 60%. … We remain committed to our medium-term financial targets. We continue to forecast ongoing revenue growth of...
investors.spirehealthcare.comThe latest company information, including net asset values, performance, holding & sectors weighting, changes in voting rights, and directors and dealings.
markets.ft.com– Increased private revenue by 3.7% to £995.2 million from £959.7 million in 2023 – £112.1 million capex investment across our estate, including solar energy and three new clinics – New patient support centres – Implemented the NHS England Patient
investors.spirehealthcare.comSpire Healthcare has 38 hospitals and over 50 clinics and medical centres across England, Wales and Scotland. It operates a network of private GPs and provides occupational health services to ... Read more
www.nhsforsale.info